Risk of skin neoplasm related to the use of immunomodulatory abatacept (2016)
- Authors:
- Autor USP: KANO, EUNICE KAZUE - FCF
- Unidade: FCF
- Subjects: NEOPLASIAS; ADJUVANTES IMUNOLÓGICOS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 52, suppl. 1, p. 47 res. FCF090, 2016
- Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo
-
ABNT
PEDRO, Letícia Sybilla Borges e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Risk of skin neoplasm related to the use of immunomodulatory abatacept. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 23 abr. 2024. , 2016 -
APA
Pedro, L. S. B., Ribeiro, A. G., & Kano, E. K. (2016). Risk of skin neoplasm related to the use of immunomodulatory abatacept. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Pedro LSB, Ribeiro AG, Kano EK. Risk of skin neoplasm related to the use of immunomodulatory abatacept. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 47 res. FCF090.[citado 2024 abr. 23 ] -
Vancouver
Pedro LSB, Ribeiro AG, Kano EK. Risk of skin neoplasm related to the use of immunomodulatory abatacept. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 47 res. FCF090.[citado 2024 abr. 23 ] - Osteonecrosis of jaw in use of bisphosphonates
- Assessment of safety and effectivity associated to oseltamivir therapy
- New oral anticoagulants: what do their adverse drug reactions reports suggest?
- Avaliação de diferentes cronogramas de coletas de amostras biológicas em estudos de bioequivalência e análise da influência do teor de fármaco sobre os resultados destes estudos
- Isotretinoin use association with tetratogenic effect and psychiatric disorders: need to improve risk management
- Adverse drug reactions related to use of interferon beta-1A, interferon beta-1B and glatiramer for multiple sclerosis treatment
- Evaluation of the effects of different sampling schedules on the assessment of bioequivalence of long half life drug
- Desenvolvimento e validação de método bioanalítico para quantificação de fluconazol em plasma humano
- Risk of tuberculosis associated with therapy based on inhibitors of TNF-alpha
- Cardiovascular adverse drug reaction profile of formoterol
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
